Zacks Investment Research on MSN
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?
Pfizer PFE will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales ...
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...
Pfizer Inc. (NYSE:PFE) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 27, Berenberg Bank ...
Barchart on MSN
Pfizer Stock: Is Wall Street Bullish or Bearish?
Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s ...
One struggling pharma stock that could use a boost from a strong earnings report is Pfizer (NYSE: PFE). The company's valuation has plummeted in recent years as patent cliffs and ...
Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE) and Dow (DOW) discussed.
Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 19, Pfizer Inc. (NYSE:PFE ...
Pfizer Inc. (NYSE:PFE) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Pfizer Inc. (NYSE:PFE) ...
Zacks Investment Research on MSN
Earnings Preview: Pfizer (PFE) Q3 Earnings Expected to Decline
Pfizer (PFE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback